GlassScriptPhysician profile
Morris V Epstein
NPI 1114982071
$2,454.32
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $566.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $481.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $414.12 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $392.62 | 2019-2020 | |
| Amarin Pharma, INC. | $368.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $153.31 | 2019-2020 | |
| Lilly USA, LLC | $109.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $92.14 | 2019-2020 | |
| Pfizer INC. | $91.42 | 2019-2020 | |
| Amgen INC. | $66.75 | 2019 | |
| Abbvie INC. | $61.42 | 2019 | |
| Allergan, INC. | $29.33 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $24.32 | 2020 | |
| Mylan Specialty L.P. | $21.94 | 2019 | |
| Eisai INC. | $21.13 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.88 | 2019 | |
| Celgene Corporation | $18.79 | 2019 | |
| Zyla Life Sciences, INC. | $15.66 | 2019 | |
| Phadia US INC. | $15.02 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.45 | 2019 | |
| Glaxosmithkline, LLC. | $11.27 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.